Á¦ ¸ñ    sgNoliacGwYwXzmUSL
ÀÌ ¸§    Paris ³¯ Â¥    2018/06/28 Á¶ ȸ    1


real beauty page zp technologies ltd For lead investigator Jean-Charles Soria, the one-in-four response rate, where patients saw their tumors shrink, flags the potential of this treatment in helping patients fight back against a particularly lethal kind of cancer. Tumor shrinkage is a widely used indication that a drug is active and spurring a response which has promise in promoting patients' survival rate. A total of 53 patients were recruited for this early study, most of whom were smokers.